Neogenomics Inc

NEO

Equity

ISIN null / Valor 1589606

NASDAQ (2026-10-16)

USD 16.65-3.48%

Neogenomics Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

NeoGenomics Inc is a specialized laboratory and diagnostics company with a primary focus on cancer-related services. For over 18 years, it has been at the forefront of providing comprehensive testing and analysis for cancer diagnostics and clinical trials. The company operates on a global scale, employing a diverse team of professionals including physicians, scientists, and laboratory experts. These professionals collaborate closely with cancer care teams to offer critical oncological insights, aiming to significantly improve patient outcomes. NeoGenomics positions itself as a key player in the oncology sector by offering a range of services tailored to meet the needs of oncologists, pathologists, pharmaceutical companies, and academic institutions. Its offerings encompass diagnostic services, pharmaceutical services, and information services, all designed to facilitate the advancement of cancer care and treatment. Through its dedication to innovation and patient care, NeoGenomics strives to contribute to the development of new and improved cancer therapies, thereby enhancing the quality of life for those affected by cancer.

Summarized from source with an LLMView SourceSector: Finance

Latest Results ():

Summarized from source with an LLMView Source

Key figures

62.0%1Y

31.6%3Y

-61.6%5Y

Performance

52.5%1Y

65.1%3Y

71.0%5Y

Volatility